Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GRML
GRML logo

GRML Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Greenland Mines Ltd (GRML) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.360
1 Day change
-1.62%
52 Week Range
--
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Greenland Mines Ltd (GRML) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is facing significant challenges, including a failure to meet Nasdaq's minimum bid price requirements, poor financial performance, and no clear positive trading or sentiment signals. While the company has potential catalysts like its Skaergaard Project and diversification into cell and gene therapy, these are long-term plays that may not align with the user's investment goals or risk tolerance.

Technical Analysis

The stock experienced a significant regular market drop of -14.65%, with slight recovery in post-market (+3.48%) and pre-market (+4.26%) trading. However, there is no clear trend or strong recovery signal, and the broader market (S&P 500) also declined by -1.79%.

Positive Catalysts

  • The Skaergaard Project, with an estimated resource value of $68 billion, and diversification into cell and gene therapy with KLTO-202 for ALS, could be long-term growth drivers.

Neutral/Negative Catalysts

  • The company is at risk of being delisted from Nasdaq due to its failure to meet the minimum bid price requirement. Financial performance is weak, with declining net income and EPS. There are no significant trading trends from hedge funds or insiders.

Financial Performance

In 2025/Q3, the company reported zero revenue growth (0.00% YoY), a net income drop to -$2,895,585 (-2.16% YoY), and a significant EPS decline of -72.22% YoY. Gross margin remains at 0, indicating no profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Wall Street analysts forecast GRML stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast GRML stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 0.370
sliders
Low
0
Averages
0
High
0
0
Current: 0.370
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch